武田制药 | 14.90 +0.07 +0.47% | ||
| TAK | |||
| 高 15.01 | 开 14.78 | 量 506.51万股 | 总市值 470.72亿 |
| 低 14.74 | 换 0.16% | 额 7564.64万 | 市盈TTM 224.05 |
分时
5日
日K
周K
月K
季K
年K
武田制药(TAK)
12-18 19:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000174 Act: 34 Size: 60 KB 网页链接
武田制药(TAK)
12-10 10:25
$武田制药(TAK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000172 Act: 34 Size: 10 KB 网页链接
武田制药(TAK)
12-10 10:05
$武田制药(TAK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001395064-25-000167 Size: 20 KB 网页链接
武田制药(TAK)
12-09 19:15
$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977746-25-000006 Act: 33 Size: 5 KB 网页链接
武田制药(TAK)
12-08 19:25
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000164 Act: 34 Size: 128 KB 网页链接
武田制药(TAK)
12-05 19:15
$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977608-25-000006 Act: 33 Size: 5 KB 网页链接
武田制药(TAK)
12-04 19:05
$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977620-25-000007 Act: 33 Size: 4 KB 网页链接
武田制药(TAK)
11-28 19:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000161 Act: 34 Size: 2 MB 网页链接
武田制药(TAK)
11-13 21:05
$武田制药(TAK)$ 13F-HR Quarterly report filed by institutional managers, Holdings Accession Number: 0001395064-25-000157 Act: 34 Size: 7 KB 网页链接
武田制药(TAK)
10-30 18:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000150 Act: 34 Size: 60 KB 网页链接
武田制药(TAK)
10-30 18:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000152 Act: 34 Size: 1 MB 网页链接
武田制药(TAK)
10-30 18:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000154 Act: 34 Size: 1 MB 网页链接
武田制药(TAK)
10-01 21:25
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000145 Act: 34 Size: 25 KB 网页链接
武田制药(TAK)
09-25 18:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000143 Act: 34 Size: 35 KB 网页链接
武田制药(TAK)
09-19 19:25
$武田制药(TAK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000140 Act: 34 Size: 8 KB 网页链接
武田制药(TAK)
09-19 19:25
$武田制药(TAK)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001395064-25-000138 Size: 56 KB 网页链接
武田制药(TAK)
09-08 18:25
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000130 Act: 34 Size: 15 MB 网页链接
武田制药(TAK)
08-21 18:05
$武田制药(TAK)$ N-PX Annual Report of proxy voting record of management investment companies Accession Number: 0001395064-25-000128 Act: 34 Size: 6 KB 网页链接
武田制药(TAK)
08-08 18:15
$武田制药(TAK)$ 13F-HR Quarterly report filed by institutional managers, Holdings Accession Number: 0001395064-25-000124 Act: 34 Size: 8 KB 网页链接
武田制药(TAK)
07-31 18:15
$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000122 Act: 34 Size: 739 KB 网页链接